21481 ⎘
Preparations for testing; Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier; Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
Sub-classes:SYSTEMS AND METHODS OF DETECTING INTERSTITIAL CYSTITIS
#2METHODS FOR PROTON-ONLY DETECTION OF HYPERPOLARIZED HETERONUCLEAR SINGLET STATES
#3COMPOSITION AND METHOD FOR DIAGNOSTIC IMAGING
#4CHARACTERISING LESIONS IN THE LIVER USING DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE TOMOGRAPHY
#5MULTI-MODALITY MOLECULAR IMAGING PROBE, AND PREPARATION METHOD AND USE THEREOF
#6PROBES, SYSTEMS, AND METHODS FOR MAGNETIC RESONANCE PH SENSING
#7METHOD FOR MULTIMODAL TISSUE IMAGING BASED ON RESONANCE RAMAN EFFECT ON METAL BASED MRI CONTRAST AGENTS AND METHOD FOR IONIZING LASER PLUMES THROUGH ATMOSPHERIC PRESSURE CHEMICAL IONIZATION
#8MAGNETIC RESONANCE IMAGING CONTRAST AGENT, PREPARATION METHOD AND USE THEREOF
#9GENERATION OF MRI IMAGES OF THE LIVER WITHOUT CONTRAST ENHANCEMENT
#10SOLVENT FREE GADOLINIUM CONTRAST AGENTS
#11Methods for Cell Labeling and Medical Imaging
#12Polarisation transfer via a second metal complex
#13Manganese-based chelate conjugates for molecular MR imaging
#14Tailored dose of contrast agent
#15Cardiac late gadolinium enhancement MRI for patients with implanted cardiac devices
#16CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING
#17Preparation of a solid form of gadobenate dimeglumine
#18Solvent-free gadolinium contrast agents
#19Method for joint arterial input function and tracer kinetic parameter estimation in accelerated DCE-MRI using a model consistency constraint
#20Method for multimodal tissue imaging based on resonance Raman effect on metal based MRI contrast agents and method for ionizing laser plumes through atmospheric pressure chemical ionization
#21Gadolinium contrast agents, scavenging methods, and scavenging system
#22Metal complexes with bisphophonate or pyrophosphate useful as imaging agents
#23USE OF A REVERSE-MICELLAR SYSTEM FOR DELIVERING CHELATORS OF RADIONUCLIDES AND METALS
#24Cell-permeable imaging sensors and uses thereof
#25Manganese complexes with substituted bisphosphonates useful as imaging and therapeutic agents
#26SYSTEMS AND METHODS OF DETECTING INTERSTITIAL CYSTITIS
#27Manganese-based chelate conjugates for molecular MR imaging
#28Solvent-Free Gadolinium Contrast Agents
#29Crystalline contrast agent for magnetic resonance imaging, kit and composition comprising it and their use
#30Methods for cell labeling and medical imaging
#31Ethylenediaminetetraacetic acid bis(amide) derivatives and their respective complexes with Mn(II) ion for use as MRI contrast agent
#32Metal complexes with bisphosphonate useful as imaging agents
#33MRI signal suppression agents, compositions, and methods
#34MRI-guided intraarterial catheter-based method for predicting territory of local blood brain barrier opening
#35Magnetic resonance imaging contrast agent capable of detecting hydrogen peroxide and reducing reactive oxygen species
#36Use of a reverse-micellar system for delivering chelators of radionuclides and metals
#37N-alkoxyamide conjugates as imaging agents
#38Systems and methods for extracting prognostic image features
#39System and method for magnetic resonance imaging
#40Iron-salen complex
#41N-alkoxyamide conjugates as imaging agents
#42Cobalt-based MRI contrast agent and imaging system
#43Imaging diagnostics by combining contrast agents
#44Cardiac late gadolinium enhancement MRI for patients with implanted cardiac devices
#45Manganese-based magnetic resonance contrast agents
#46Nuclear magnetic resonance diagnostic agent, and method for detecting or diagnosing state of cell, tissue or organ in subject using same
#47Contrast Agent and Applications Thereof
#48Contrast agent for nuclear magnetic resonance imaging comprising melanin nanoparticles stably dispersed in water
#49N-alkoxyamide conjugates as imaging agents
#50DTPA DERIVATIVE, METAL COMPLEX, MR AND CT CONTRAST AGENT AND METHOD FOR MANUFACTURING SAME
#51Self-magnetic metal-salen complex compound
#52Lipidomimetic compounds and uses thereof
#53BIFUNCTIONAL CHELATING AGENTS
#54CONTAINER WITH CONCENTRATED SUBSTANCE AND METHOD OF USING THE SAME
#55Uridine-based gadolinium complex and MRI contrast agent including the same
#56N-alkoxyamide conjugates as imaging agents
#57Methods and compositions for objectively characterizing medical images
#58Compositions and methods for treating nephropathy
#59GLYCOCONJUGATES AND METHODS
#60Paramagnetic polynuclear metal complex having high self-relaxation rate, preparation method thereof, and contrast medium containing same
#61MRI markers, delivery and extraction systems, and methods of manufacture and use thereof
#62DTPA DERIVATIVE, METAL COMPLEX, MR AND CT CONTRAST AGENT AND METHOD FOR MANUFACTURING SAME
#63VITAL FLUOROCHROME CONJUGATES AND METHODS OF USE
#64Diagnostic imaging contrast agents with extended blood retention
#65Complex compound and MRI probe made of same
#66System and method for magnetic resonance imaging
#67Hydroxylated contrast enhancement agents
#68Hydroxylated contrast enhancement agents and imaging method
#69IMAGING DIAGNOSTICS BY COMBINING CONTRAST AGENTS
#70Complex Compound and MRI Probe Made of Same
#71Diagnostic agents selective against metalloproteases
#72INTERMEDIATES FOR HYDROXYLATED CONTRAST ENHANCEMENT AGENTS
#73Hydroxylated contrast enhancement agents
#74Removal of silica from water soluble compounds by nanofiltration and reverse phase chromatography
#75Use of the spin crossover complex [m(L)H]AN)as a magnetic resonance imaging contrast agent
#76Particles for imaging
#77NOVEL LANTHANIDE LIGANDS AND COMPLEXES, AND USE THEREOF AS CONTRAST AGENTS
#78Method of hyperpolarising a magnetic resonance agent
#79Magnetic resonance imaging
#80Hyperpolarized 89-yttrium and methods relating thereto
#81Chelating agents
#82Diagnostic substance and method for the analysis of metabolism processes in the brain
#83Perfluoroalkyl-Containing Complexes, Process For Their Production As Well As Their Use
#84N-alkoxyamide conjugates as imaging agents
#85Higher fatty acid triester and amide derivative having diethylenetriamine-type metal chelate structure
#86In vivo mitochondrial labeling using positively-charged nitroxide enhanced and gadolinium chelate enhanced magnetic resonance imaging
#87IRON-SALEN COMPLEX
#88Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
#89Method of magnetic resonance imaging of the heart with paramagnetic MN
#90PHTHALAMIDE-LANTHANIDE COMPLEXES FOR USE AS LUMINESCENT MARKERS
#91NEUTRAL LABELING REACTANTS AND CONJUGATES DERIVED THEREOF
#92Chelating agents with lipophilic carriers
#93Manganese-enhanced magnetic resonance imaging of neurons using electrical stimulation
#94Use of perfluoroalkyl-containing metal complexes as contrast media for diagnosis of Alzheimer's disease
#95Cycloalkyl triamine pentacarboxylate as ligands for paramagnetic metal complexes
#96Polyamine-substituted ligands for use as contrast agents
#97Perfluoroalkyl-containing complexes, process for their production as well as their use
#98Neutral labeling reactants and conjugates derived thereof
#99Mri contrast medium composition for oral administration
#100Diagnostic imaging contrast agents with extended blood retention
#101Diagnostic imaging contrast agents with extended blood retention
#102Perfluoroalkyl-containing complexes, process for their production as well as their use
#103Hydroxypyridinone derivatives, metal complexes thereof and the use thereof for preparing conjugates with biomolecules
#104Diagnostic imaging contrast agents with extended blood retention
#105Conjugates of hydroxypyridinone derivative metal complexes with biomolecules and their use for MRI diagnosis
#106Chemical exchange saturation transfer contrast agents
#107Bioactivated diagnostic imaging contrast agents
#108Pharmaceutical agents that contain fluoroalkyl-containing metal complexes and epothilones
#109DTPA derivatives and metal complexes thereof, and radiation source and contrast agent including the metal complexes
#110Magnetic resonance imaging method and compounds for use in the method
#111Steady state perfusion methods
#112Magnetic resonance imaging of metal concentrations
#113Paramagnetic complexes with pendant crown compounds showing improved targeting-specificity as MRI contrast agents
#114Galactopyrannosyltriaminetetracarboxylate as ligands for bioactivated paramagnetic metal complexes
#115Glycoconjugates and methods
#116Contrast agents
#117Contrast-enhanced diagnostic imaging method for monitoring interventional therapies
#118Phthalamide-lanthanide complexes for use as luminescent markers
#119Polypodal chelants for metallopharmaceuticals
#120Hydroxypyridonate and hydroxypyrimidinone chelating agents
#121Magnetic resonance imaging agents for the detection of physiological agents